Type 2 diabetes Nutritional, Metabolic, Endocrine
Conditions
Interventions
The intervention consists of a 12-week supervised exercise program with or without ischemic preconditioning (IPC), depending on group allocation
Tai Chi Program
Participants assigned to the Tai Chi
Sponsors
Centrum Medyczne Provita
Upper Silesian Academy in Katowice
Eligibility
Sex/Gender
All
Age
100 Years to 200 Years
Inclusion criteria
Inclusion criteria: 1. Individuals aged =50 years (no upper age limit, provided that clinical status allows safe participation). 2. Diagnosed with type 2 diabetes mellitus (T2DM) according to current diagnostic criteria. 3. Duration of diabetes of at least 6 months. 4. No changes in antidiabetic treatment (type of medication or dosage) for at least 3 months prior to study enrolment. 5. No planned changes in pharmacological treatment during the 12-week intervention period. 6. No regular exercise habits, defined as: 6.1. No structured training-type physical activity =1 session per week during the past 3–6 months. 6.2. Occasional low-intensity recreational activity (e.g., walking) is permitted. 7. Ability to ambulate independently. 8. Ability to safely participate in low- to moderate-intensity exercise (Tai Chi) as assessed by a qualifying physician or physiotherapist. 9. Signed informed consent to participate in the study. 10. Consent to undergo laboratory testing and clinical measurements.
Exclusion criteria
Exclusion criteria: 1. Cardiovascular and Systemic Contraindications 1.1. Unstable coronary artery disease. 1.2. Myocardial infarction or stroke within 1.10). 3.4. Intolerance to limb compression or significant pain during the preliminary IPC procedure test. 4. Orthopedic and Functional Contraindications 4.1. Acute inflammation, injury, or exacerbation of musculoskeletal disorders. 4.2. Significant mobility limitations or deformities preventing the performance of Tai Chi exercises, even in a modified form. 4.3. Recent surgery (<6 months). 5. Other Exclusion Factors 5.1. Active malignancy under current treatment. 5.2. Severe cognitive impairment or psychiatric disorders preventing informed participation. 5.3. Participation in another clinical trial or interventional study within the past 3 months. 5.4. Lack of informed consent or withdrawal of consent at any stage of the study.Adherence Criterion: Participants are required to attend at least 70% of the scheduled exercise sessions. Individuals whose attendance falls below 70% of the total planned sessions during the 12-week intervention will be excluded from the final analysis.
Countries
Poland
Contacts
Public ContactRobert Trybulski
Outcome results
None listed